233 related articles for article (PubMed ID: 8069866)
1. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines.
Sekido Y; Bader SA; Carbone DP; Johnson BE; Minna JD
Cancer Res; 1994 Sep; 54(18):4988-92. PubMed ID: 8069866
[TBL] [Abstract][Full Text] [Related]
2. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
3. Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
Cho JH; Noguchi M
J Korean Med Sci; 1997 Aug; 12(4):305-10. PubMed ID: 9288629
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
5. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
Güre AO; Altorki NK; Stockert E; Scanlan MJ; Old LJ; Chen YT
Cancer Res; 1998 Mar; 58(5):1034-41. PubMed ID: 9500467
[TBL] [Abstract][Full Text] [Related]
6. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas.
Jackson D; Waibel R; Weber E; Bell J; Stahel RA
Cancer Res; 1992 Oct; 52(19):5264-70. PubMed ID: 1327504
[TBL] [Abstract][Full Text] [Related]
7. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.
Szabo A; Dalmau J; Manley G; Rosenfeld M; Wong E; Henson J; Posner JB; Furneaux HM
Cell; 1991 Oct; 67(2):325-33. PubMed ID: 1655278
[TBL] [Abstract][Full Text] [Related]
8. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
[TBL] [Abstract][Full Text] [Related]
9. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
Yu Q; Mirski SE; Sparks KE; Cole SP
Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
11. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
12. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
[TBL] [Abstract][Full Text] [Related]
13. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis.
Dropcho EJ
Ann Neurol; 1996 May; 39(5):659-67. PubMed ID: 8619552
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
[TBL] [Abstract][Full Text] [Related]
15. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
16. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
17. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.
Dalmau J; Furneaux HM; Gralla RJ; Kris MG; Posner JB
Ann Neurol; 1990 May; 27(5):544-52. PubMed ID: 2163235
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
19. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
20. Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Matsumoto T; Ryuge S; Kobayashi M; Kageyama T; Hattori M; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
Int J Oncol; 2012 Jun; 40(6):1957-62. PubMed ID: 22426972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
